KURA — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

16.79

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

-0.03

EPS Last/This Y

-0.17

EPS This/Next Y

0.91

Price

8.82

Target Price

31.91

Analyst Recom

1.21

Performance Q

-7.55

Upside

-1,361.9%

Beta

0.27

Ticker: KURA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	KURA	9.39	0.54	0.02	16309
2026-03-10	KURA	9.27	0.53	0.06	16545
2026-03-11	KURA	9.21	0.52	0.06	16764
2026-03-12	KURA	8.84	0.52	1.88	16893
2026-03-13	KURA	8.84	0.52	0.45	16893
2026-03-17	KURA	8.59	0.50	0.00	17227
2026-03-18	KURA	8.4	0.50	0.00	17235
2026-03-19	KURA	8.42	0.50	0.05	17191
2026-03-20	KURA	8.26	0.50	0.10	17244
2026-03-23	KURA	8.31	0.27	0.11	10884
2026-03-24	KURA	8.08	0.26	0.03	11227
2026-03-25	KURA	8.55	0.26	0.02	11613
2026-03-26	KURA	8.38	0.25	0.00	11839
2026-03-27	KURA	7.75	0.25	15.17	11880
2026-03-30	KURA	7.72	0.31	0.48	12386
2026-03-31	KURA	8.11	0.32	0.52	12532
2026-04-01	KURA	8.32	0.32	0.25	12748
2026-04-02	KURA	8.61	0.32	0.04	12742
2026-04-06	KURA	8.51	0.31	0.07	13218
2026-04-07	KURA	8.83	0.31	0.00	13170
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	KURA	9.38	-41.9	-170.7	-3.27
2026-03-10	KURA	9.26	-41.9	-109.8	-3.27
2026-03-11	KURA	9.22	-41.9	-114.8	-3.27
2026-03-12	KURA	8.84	-41.9	-80.4	-3.27
2026-03-13	KURA	8.65	-11.5	-342.7	-3.27
2026-03-17	KURA	8.58	-11.5	-23.6	-3.27
2026-03-18	KURA	8.40	-11.5	-9.3	-3.27
2026-03-19	KURA	8.42	-11.5	-47.6	-3.27
2026-03-20	KURA	8.26	-11.5	3.9	-3.27
2026-03-23	KURA	8.31	-11.5	-62.7	-3.27
2026-03-24	KURA	8.07	-11.5	36.1	-3.27
2026-03-25	KURA	8.55	-11.5	-250.9	-3.27
2026-03-26	KURA	8.38	-11.5	-2.0	-3.27
2026-03-27	KURA	7.74	-11.5	146.3	-3.27
2026-03-30	KURA	7.72	-11.5	-31.7	-3.27
2026-03-31	KURA	8.11	-11.5	-359.9	-3.27
2026-04-01	KURA	8.32	-11.5	-123.4	-3.27
2026-04-02	KURA	8.62	-11.5	-133.7	-3.27
2026-04-06	KURA	8.51	-12.1	-20.7	-3.35
2026-04-07	KURA	8.82	-12.1	-125.2	-3.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	KURA	-4.99	0.96	16.40
2026-03-10	KURA	-6.63	0.96	16.40
2026-03-11	KURA	-6.63	0.96	17.03
2026-03-12	KURA	-6.63	0.96	17.03
2026-03-13	KURA	-6.63	0.96	17.03
2026-03-17	KURA	-6.63	0.94	17.03
2026-03-18	KURA	-6.63	0.94	17.03
2026-03-19	KURA	-6.63	0.94	17.03
2026-03-20	KURA	-6.63	0.94	17.03
2026-03-23	KURA	-6.63	0.94	17.03
2026-03-24	KURA	-6.63	0.94	17.03
2026-03-25	KURA	-6.63	0.94	16.79
2026-03-26	KURA	-6.63	0.94	16.79
2026-03-27	KURA	-6.63	0.94	16.79
2026-03-30	KURA	-4.05	0.93	16.79
2026-03-31	KURA	-4.05	0.93	16.79
2026-04-01	KURA	-4.05	0.93	16.79
2026-04-02	KURA	-4.05	0.93	16.79
2026-04-06	KURA	-4.05	0.91	16.79
2026-04-07	KURA	-4.05	0.91	16.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.92

Avg. EPS Est. Current Quarter

-0.74

Avg. EPS Est. Next Quarter

-0.95

Insider Transactions

-4.05

Institutional Transactions

0.91

Beta

0.27

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

70.9

Max Drawdown 5-Year %

-81.5

Target Price

31.91

P/E

Forward P/E

PEG

P/S

11.55

P/B

4.45

P/Free Cash Flow

EPS

-3.18

Average EPS Est. Cur. Y

-3.35

EPS Next Y. (Est.)

-2.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-412.95

Relative Volume

0.97

Return on Equity vs Sector %

-187.5

Return on Equity vs Industry %

-170.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.29

EBIT Estimation

-125.2

◆ KURA Healthcare

$8.82

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

6/25

Volume

7/15

Valuation

14/20

TP/AR

4/10

Options

7/10

RSI

56.2

Range 1M

57.9%

Sup Dist

5.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

10/30

Estimates

3/20

Inst/Vol

5/15

Options

8/10

EPS Yr

-10.7%

EPS NY

26.5%

52W%

46.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +261.8% upside

Quality

6/30

Valuation

17/30

Growth

7/25

Stability

9/10

LT Trend

2/5

Upside

+261.8%

Quality

Kura Oncology, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 260

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

KURA

Latest News

—

Caricamento notizie per KURA…

stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today

news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance

stock history KURA – Kura Oncology, Inc. invest stock market

stock prices KURA premarket after hours

ticker KURA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KURA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y